We are live on ! Find out more
GWM

GSB Wealth Management Portfolio holdings

AUM $443M
1-Year Est. Return 17.59%
This Fund
S&P 500
This Quarter Est. Return
+3.02%
1 Year Est. Return
+17.59%
3 Year Est. Return
+45.9%
5 Year Est. Return
+57.79%
10 Year Est. Return
–
AUM
$21.1M
AUM Growth
-$954K
Cap. Flow
-$1.4M
Cap. Flow %
-6.63%
Top 10 Hldgs %
42.28%
Holding
58
New
2
Increased
5
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
DNP icon
DNP Select Income Fund
DNP
+$470K
2
DD icon
DuPont de Nemours
DD
+$272K
3
ABBV icon
AbbVie
ABBV
+$206K
4
BAC icon
Bank of America
BAC
+$3.79K
5
SAN icon
Banco Santander
SAN
+$2.18K

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$509K
2
ABT icon
Abbott
ABT
+$437K
3
ACN icon
Accenture
ACN
+$385K
4
PAYX icon
Paychex
PAYX
+$296K
5
JNJ icon
Johnson & Johnson
JNJ
+$267K

Sector Composition

Rank Sector Weight
1 Industrials 19.02%
2 Healthcare 12.17%
3 Consumer Staples 12.14%
4 Energy 10.88%
5 Utilities 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HON icon
26
Honeywell
HON
$77B
$323K 1.53%
2,524
– –
CLX icon
27
Clorox
CLX
$11.6B
$320K 1.51%
2,425
– –
BHP icon
28
BHP
BHP
$213B
$318K 1.5%
8,800
– –
XEL icon
29
Xcel Energy
XEL
$51B
$318K 1.5%
6,730
– –
TTE icon
30
TotalEnergies
TTE
$193B
$305K 1.44%
5,702
– –
AEP icon
31
American Electric Power
AEP
$73.7B
$299K 1.41%
4,250
– –
MCY icon
32
Mercury Insurance
MCY
$5.94B
$295K 1.4%
5,200
– –
BA icon
33
Boeing
BA
$165B
$294K 1.39%
1,158
– –
BMY icon
34
Bristol-Myers Squibb
BMY
$127B
$293K 1.39%
4,600
– –
CHD icon
35
Church & Dwight Co
CHD
$23.1B
$291K 1.38%
6,000
– –
DD icon
36
DuPont de Nemours
DD
$18.6B
$286K 1.35%
+1,630
New +$272K
PM icon
37
Philip Morris
PM
$301B
$278K 1.31%
2,500
– –
VGK icon
38
Vanguard FTSE Europe ETF
VGK
$30B
$268K 1.27%
4,600
– –
PPL
39
PPL Corp
PPL
$27.3B
$266K 1.26%
7,000
– –
PARA
40
DELISTED
Paramount Global Class B
PARA
$264K 1.25%
4,557
+13
+0.3% +$821
MCD icon
41
McDonald's
MCD
$188B
$256K 1.21%
1,636
– –
SPG icon
42
Simon Property Group
SPG
$74.5B
$242K 1.14%
1,500
– –
ABBV icon
43
AbbVie
ABBV
$458B
$240K 1.14%
+2,701
New +$206K
EFX icon
44
Equifax
EFX
$20.3B
$235K 1.11%
2,219
– –
ORAN
45
DELISTED
Orange
ORAN
$213K 1.01%
12,980
– –
RTX icon
46
RTX Corp
RTX
$287B
$209K 0.99%
2,860
– –
WDC icon
47
Western Digital
WDC
$179B
$209K 0.99%
3,206
– –
ED icon
48
Consolidated Edison
ED
$41.6B
$204K 0.96%
2,530
– –
PSK icon
49
State Street SPDR ICE Preferred Securities ETF
PSK
$693M
$202K 0.96%
4,515
– –
RAD
50
DELISTED
Rite Aid Corporation
RAD
$141K 0.67%
3,588
– –
1
2
3

Similar funds

CP
Cornerstone Planning Charlotte, North Carolina $443M AUM
CMP
Coston McIsaac & Partners Bar Harbor, Maine $443M AUM 6.68% 1-Year Est. Return
BFA
Beacon Financial Advisory Cleveland, Ohio $443M AUM 17.02% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
HBT
Heartland Bank & Trust Bloomington, Illinois $442M AUM 28.29% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $444M AUM 24.8% 1-Year Est. Return

GSB Wealth Management's Q3 2017 Portfolio in Review

As of Q3 2017, GSB Wealth Management held 58 positions worth $21.1M, down 4.3% from $22.1M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GSB Wealth Management withdrew a net $1.4M in Q3 2017, closing 6 positions and reducing 1 holding. Its most notable exit was AstraZeneca, an estimated $509K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, GSB Wealth Management opened a new position in DuPont de Nemours worth $286K.

  • GSB Wealth Management's largest Q3 2017 buy was DuPont de Nemours: 1,630 shares worth $286K.
  • GSB Wealth Management added most to DNP Select Income Fund in Q3 2017, an estimated $470K increase.
  • GSB Wealth Management's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $267K.
  • GSB Wealth Management fully exited AstraZeneca in Q3 2017, selling an estimated $509K.
  • GSB Wealth Management's ten largest holdings make up 42% of its $21.1M portfolio in Q3 2017.
  • GSB Wealth Management opened 2 new positions and closed 6 in Q3 2017.
  • GSB Wealth Management's portfolio value fell 4.3% quarter-over-quarter to $21.1M.

Based on GSB Wealth Management's 13F filing for Q3 2017, filed 24 Nov 2017.